ReplyThomas A. Baillie; Mitchell N. Cayen; Hassan Fouda; Ronald J. Gerson; James D. Green; Scott J. Grossman; Lewis J. Klunk; Bernard LeBlanc; Darcy G. Perkins; Lisa A. Shipley · 2003

METABOLIC DISPOSITION OF CLOFIBRATECayen, Mitchell N. · Drug Metabolism and Drug Interactions · 1980

Agents Affecting Lipid MetabolismCAYEN, MITCHELL N. · The American Journal of Clinical Nutrition · 1970

Pharmacokinetics of Intramuscularly Administered Isepamicin in ManLin, Chin-chung; Radwanski, Elaine; Korduba, Chryzanta; Affrime, Melton; Cayen, Mitchell N. · Chemotherapy · 1997

Hypolipidemic activity of 2,8-dibenzyl-cyclooctanone in ratsMitchell N. Cayen; Jean Dubuc; Dushan Dvornik · 1976

Drug Metabolites in Safety TestingThomas A. Baillie; Mitchell N. Cayen; Hassan Fouda; Ronald J. Gerson; James D. Green; Scott J. Grossman; Lewis J. Klunk; Bernard LeBlanc; Darcy G. Perkins; Lisa A. Shipley · 2002

Metabolic Disposition of Antihyperlipidemic Agents in Man and Laboratory AnimalsCayen, Mitchell N. · Drug Metabolism Reviews · 1980

Hypolipidemic 4,5-dihydro-4-oxo-5,5-disubstituted-2-furancarboxylic acidsJirkovsky, Ivo; Cayen, Mitchell N. · Journal of Medicinal Chemistry · 1982